Acute human defibrillation performance of a subcutaneous implantable cardioverter-defibrillator with an additional coil electrode

被引:4
|
作者
Yap, Sing -Chien [7 ,8 ]
Oosterwerff, Erik F. J. [6 ]
Boersma, Lucas V. A. [1 ,2 ]
van der Stuijt, Willeke [2 ]
Lenssen, Anneke [4 ]
Hahn, Stephen J. [5 ]
Knops, Reinoud E. [3 ]
机构
[1] Erasmus MC, Cardiovasc Inst, Thorax Ctr, Dept Cardiol, Rotterdam, Netherlands
[2] Isala Klin, Dept Cardiol, Zwolle, Netherlands
[3] St Antonious Ziekenhuis, Dept Cardiol, Nieuwegein, Netherlands
[4] Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands
[5] Boston Sci, Amsterdam, Netherlands
[6] Boston Sci CRM, St Paul, MN USA
[7] Flevo Hosp, Almere, Netherlands
[8] Erasmus MC, Dept Surg, Doctor Molenwaterpl 40, NL-3015 GD Rotterdam, Netherlands
关键词
Defibrillation; Subcutaneous; Human; Electrodes; Implantable cardioverter-defibrillator; OUTCOMES; TRIAL; ICD;
D O I
10.1016/j.hrthm.2023.08.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) delivers 80 J shocks from an 8 cm left-parasternal coil to a 59 cm(3) left lateral pulse generator (PG). A system that defibrillates with lower energy could significantly reduce PG size. Computer modeling and animal studies suggested that a second shock coil either parallel to the left-parasternal coil or transverse from the xiphoid to the PG pocket would significantly reduce the defibrillation threshold.Objective The purpose of this study was to acutely assess the defibrillation efficacy of parallel and transverse configurations in patients receiving an S-ICD.Methods Testing was performed in patients receiving a conventional S-ICD system. Success at 65 J was required before investigational testing. A second electrode was temporarily inserted from the xiphoid incision connected to the PG with an investigational Y-adapter. Phase 1 (n = 11) tested the parallel configuration. Phase 2 (n = 21) tested both parallel and transverse configurations in random order.Results This study enrolled 35 patients (28 males (80%); mean age 51 +/- 17 years; left ventricular ejection fraction 40% +/- 15%; body mass index 26 +/- 4 kg/m(2); prior myocardial infarction 46%; congestive heart failure 49%; cardiomyopathy 63%). Compared to the conventional S-ICD system, mean shock impedance decreased for both parallel (69 +/- 15 Omega vs 86 +/- 20 Omega; n = 33; P < .001) and transverse (56 +/- 14 Omega vs 81 +/- 21 Omega; n = 20; P < .001) configurations. Shock success rates at 20, 30, and 40 J were 55%, 79%, 97%, and 25%, 70%, 90% for parallel and transverse configurations, respectively. Defibrillation threshold testing was well tolerated with no serious adverse events.Conclusion Adding a second shock coil, particularly in the parallel configuration, significantly reduced the impedance and had a high likelihood of defibrillation success at energies <= 40 J. This may enable the development of a smaller S-ICD.
引用
收藏
页码:1649 / 1656
页数:8
相关论文
共 50 条
  • [31] Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
    van der Stuijt, W.
    Quast, A. B. E.
    Knops, R. E.
    NETHERLANDS HEART JOURNAL, 2020, 28 (SUPPL 1) : 122 - 127
  • [32] A subcutaneous implantable cardioverter-defibrillator - the first implantation in Poland
    Kaczmarek, Krzysztof
    Zwolinski, Radoslaw
    Bartczak, Karol
    Ptaszynski, Pawel
    Wranicz, Jerzy Krzysztof
    Kardiologia Polska, 2015, 73 (01) : 62 - 62
  • [33] Subcutaneous implantable cardioverter-defibrillator (S-ICD)
    Lobodzinski, S. Suave
    CARDIOLOGY JOURNAL, 2011, 18 (03) : 326 - 331
  • [34] The Subcutaneous Implantable Cardioverter-Defibrillator When Less Is More
    Curtis, Anne B.
    Beck, Hiroko
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (16) : 1616 - 1618
  • [35] Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System
    Gold, Michael R.
    El-Chami, Mikhael F.
    Burke, Martin C.
    Upadhyay, Gaurav A.
    Niebauer, Mark J.
    Prutkin, Jordan M.
    Herre, John M.
    Kutalek, Steven
    Dinerman, Jay L.
    Knight, Bradley P.
    Leigh, Jill
    Lucas, Lindsay
    Carter, Nathan
    Brisben, Amy J.
    Aasbo, Johan D.
    Weiss, Raul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (05) : 383 - 397
  • [36] Lead failure in an entirely subcutaneous implantable cardioverter-defibrillator
    Kolb, Christof
    Weigand, Severin
    Schaarschmidt, Claudia
    Lennerz, Carsten
    EUROPACE, 2020, 22 (02): : 183 - 183
  • [37] SHOCK WITHOUT WIRES: A LOOK AT SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR COMPARED TO TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR FOR VENTRICULAR ARRHYTHMIAS
    Guice, K. C.
    Raja, J.
    Oberoi, M.
    Khouzam, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 493 - 493
  • [38] Twiddler's Syndrome in a Subcutaneous Implantable Cardioverter-Defibrillator
    Jin, Chengyue
    Jacobson, Jason
    Iwai, Sei
    Ferrick, Aileen M.
    CIRCULATION, 2020, 142
  • [39] First case of subcutaneous implantable cardioverter-defibrillator extrusion
    Santarpia, Giuseppe
    Polimeni, Alberto
    De Rosa, Salvatore
    Sabatino, Jolanda
    Curcio, Antonio
    Indolfi, Ciro
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 192 : 19 - 20
  • [40] Effect of posture on position of subcutaneous implantable cardioverter-defibrillator
    Pepplinkhuizen, Shari
    Spijkerboer, Anje M.
    van der Stuijt, Willeke
    de Veld, Jolien A.
    Dijkshoorn, Leonard A.
    Stenchlak, Zosja E.
    Reijerink, Marlin A. A.
    de Weger, Anouk
    Smeding, Lonneke
    Nordkamp, Louise R. A. Olde
    Wilde, Arthur A. M.
    Knops, Reinoud E.
    HEART RHYTHM, 2025, 22 (02) : 388 - 393